Skip to main content
. 2023 Sep 4;44(1):38–46. doi: 10.3343/alm.2024.44.1.38

Fig. 2.

Fig. 2

Antimicrobial susceptibilities of 503 urinary Pseudomonas aeruginosa isolates from inpatients detected between 2015 and 2020. (A) Carbapenem-susceptible isolates (N=227); (B) carbapenem-non-susceptible and non-carbapenemase producers (N=57); and (C) carbapenem-non-susceptible and carbapenemase producers (N=219). The red, pink, and green bars represent the antimicrobial-resistant, -intermediate, and -susceptible isolates, respectively.